Zhe Nie
Inventor
Stats
- 27 US patents issued
- 63 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 27 US Patents Issued
- 63 US Applications Filed
- 135 Total Citation Count
- Aug 6, 2024 Most Recent Filing
- Sep 17, 2007 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| POLARIS GROUP | 2
1 | 2007
2009 |
| CELGENE QUANTICEL RESEARCH INHIBITORS | 1
| 2017
|
| Celgene Quantical Research, Inc. | 1
| 2016
|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4
6 2 1 3 | 2008
2010 2012 2013 2015 |
| CELGENE QUANTICEL RESEARCH, INC. | 7
4 14 3 8 | 2013
2014 2015 2016 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| New York, NY, US | May 09, 24 - Feb 13, 25 |
| San Deigo, CA, US | May 14, 13 - May 14, 13 |
| San Diego, CA | Mar 20, 08 - Mar 20, 08 |
| San Diego, CA, US | Apr 14, 09 - Jul 25, 24 |
| South San Francisco, CA, US | Feb 25, 21 - Oct 10, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 34 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 11 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0051,355 | 2025 | COMPOUNDS, COMPOSITIONS, AND METHODS | 0 |
| 2024/0336,590 | 2024 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY | 0 |
| 2024/0246,969 | 2024 | HETEROCYCLIC DERIVATIVES AS CAMKK2 INHIBITORS | 0 |
| 2024/0148,732 | 2024 | TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS | 0 |
| 11944622 | 2024 | Compounds and compositions for treating conditions associated with APJ receptor activity | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.